Director, Hematological Malignancy Program
Undergraduate: University of Pennsylvania
Graduate: University of Massachusetts Medical School
Pediatric Residency: University of Massachusetts
Fellowship: Pediatric Hematology/Oncology at Columbia University
Areas of Interest and Expertise
Dr. Hochberg joined the faculty of New York Medical College in 2009, and is presently an Assistant Professor of Clinical Pediatrics within the division of Pediatric Hematology, Oncology and Stem Cell Transplantation. She specializes in hematologic malignancies, tumor lysis syndrome and late effects of cancer therapy. She is currently the Associate Director of the Pediatric Hematology/Oncology Fellowship, Associate Director of the Hematologic Malignancy Program and Clinical Director of the Wellness and Survivorship program. She currently serves as the Institutional PI for the Children’s Oncology Group. Dr. Hochberg’s research interests involve development of novel therapeutics, including genetic re-engineering of immune cells for targeted immunotherapy against pediatric leukemia and lymphoma.
Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children’s Oncology Group Report. Hochberg J, Galardy PJ, Perkins SL, Harrison L, Goldman S, Cairo MS. Br J Haematol. 2013 Nov;163(3):365-72.
Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission. Hochberg J, Khaled S, Forman SJ, Cairo MS. Br J Haematol. 2013 Apr;161(1):27-42.
Childhood and adolescent lymphoblastic lymphoma: end of the beginning and future directions. Hochberg J, Cairo MS. Pediatr Blood Cancer. 2009 Dec;53(6):917-9.
Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science. Hochberg J, Waxman IM, Kelly KM, Morris E, Cairo MS. Br J Haematol. 2009 Jan;144(1):24-40.
Insight into the biology and treatment of pediatric lymphomas: Clues from international studies. Hochberg J, Cairo MS. Pediatr Blood Cancer. 2009 Feb;52(2):153-4.
Tumor lysis syndrome: current perspective. Hochberg J, Cairo MS. Haematologica. 2008 Jan;93(1):9-13.